Risk stratification to reduce intraoperative cataract surgical complications

The authors prospectively collected data on 1135 consecutive patients undergoing cataract surgery. They were risk stratified according to categories – A (no additional risk factors, 0 points), B (vitrectomy, corneal scarring, small pupil less than 3mm, shallow anterior chamber less...

Practical application of cataract risk stratification

This study assessed the practicability of a risk stratification system, the New Zealand Cataract Risk Stratification (NZCRS) in a major teaching hospital. The scoring system was as follows: three points for Dense cataract, pseudoexfoliation (PXF), phacodonesis, previous vitrectomy and only...

Complications with porous orbital implant after enucleation in retinoblastoma patients

This is a retrospective, case control study aimed to identify risk factors associated with complications in retinoblastoma patients following primary and secondary enucleations with porous implant placements. Patients with retinoblastoma who underwent enucleation with porous orbital implant placement between January...

Outcomes of cataract surgery in eyes with weak zonules

Pseudoexfoliation (PEX) and zonular weakness have long been known to increase the risk of complication of cataract surgery. This retrospective study looks at the results of phacoemulsion and intraocular implantation in 295 eyes with pseudoexfoliation and zonular weakness, with a...

Bisphosphonates can cause orbital inflammation

The authors describe four patients with bisphosphonate induced orbital inflammation and review a further 25 cases in the literature. Intravenous zoledronate was the most common precipitant (76% of cases) with the mean time until onset of inflammation being three days...

Management of diffuse OSSN with topical chemotherapy

Ocular surface squamous neoplasia (OSSN) can be localised to the conjunctiva or, less commonly, diffusely spread over the conjunctiva and cornea. Localised OSSN can be treated by surgical removal with adjuvant cryotherapy and chemotherapy with low rates of recurrence. Diffuse...

Intravitreal injection related endophthalmitis

This article reviews the incidence, clinical findings, risk factors, management and visual outcomes in intravitreal injection related endophthalmitis. Incidence of this complication is reported to be in the range of 0.038% to 0.065% (1 in 2000-3000 injections). Patients present typically...